ESC Premium Access

What is new in venous thromboembolism?

Event: ESC CONGRESS 2017
Topic: Acute pulmonary embolism
Session type: Moderated Posters
Date: 29 August 2017
Time: 10:05 - 10:55


7 presentations in this session

Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Speaker: Doctor W. Chang (Tainan, TW)

Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)

Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Speaker: Doctor K. Hellenkamp (Goettingen, DE)

A novel experimental in vivo model of acute pulmonary embolism

Speaker: Doctor J. Schultz (Aarhus, DK)

The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Speaker: Doctor E. Klok (Leiden, NL)

Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Speaker: Doctor C. Coleman (Storrs, US)

Rivaroxaban prevents the development of chronic thromboembolic pulmonary hypertension in mice- Novel beneficial effects of the FXa inhibitor-

Speaker: Mr M. Al-Mamun (Sendai, JP)

7 speakers from this session

Doctor Wei-Ting Chang

Chi-Mei Medical Center, Tainan (Taiwan)
0 follower

Ms Caroline Sindet-Pedersen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

Doctor Kristian Hellenkamp

University Medical Center of Gottingen (UMG), Goettingen (Germany)
0 follower

Doctor Jacob Schultz

Aarhus University Hospital, Aarhus (Denmark)
0 follower

Doctor Erik Klok

Leiden University Medical Centre, Leiden (Netherlands (The))
3 presentations
0 follower

Doctor Craig Coleman

University of Connecticut , Storrs (United States of America)
8 presentations
0 follower

Mr Md Elias Al-Mamun

Tohoku University Graduate School of Medicine, Sendai (Japan)
0 follower

This platform is supported by

logo Novo Nordisk